CLINICAL_TRIALS
trial_result
· 2011-08-17
Clinical Trial Update: Study of Indacaterol Dosed in the Evening in Patients With Chronic Obstructive Pulmonary Disease (COPD) [Phase 3]
Summary
A Phase 3 study evaluating evening dosing of indacaterol in patients with chronic obstructive pulmonary disease has completed and results were posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novartis | Conditions: Chronic Obstructive Pulmonary Disease (COPD) | Phase 3 | Status: COMPLETED | Results posted: 2011-08-17